Quality, safety, and efficacy of pharmaceutical products rely on the appropriate storage and transportation conditions. Organisations having a Wholesale Distribution Authorisation (WDA) should prove that medicines are stored and distributed within the approved temperature ranges. Proper temperature mapping and cold chain WDA procedures assist in identifying environmental risks, proving that storage and distribution conditions are valid, ultimately leading to compliance with Good Distribution Practice. A proper validation programme will lead to […]

Nitrosamine risk management remains a major regulatory focus for pharmaceutical manufacturers. Although most companies have a formal risk assessment process, inspection findings are frequently due to poor scientific evidence rather than absent documentation. A solid nitrosamine scientific justification in pharma practices means that the organisation needs to underpin each individual point with good data, reasoned arguments, and up-to-date regulatory knowledge. Good scientific justification will aid […]

The European pharmaceutical industry is entering a new compliance phase with separate GMP requirements for human and veterinary medicinal products. Organisations manufacturing both product types must understand how these regulatory changes affect their quality systems. The human vs veterinary GMP split means companies will have to review documentation, manufacturing and operations to remain compliant. Early […]

Deviation Management vs. CAPA: Where Most Quality Teams Fail During Audits The pharmaceutical industry is required to have robust quality systems to deal with Governmental regulatory expectations and to safeguard product quality. Yet, a lot of audit observations arise from teams not understanding the distinction between deviation management vs CAPA. Although interconnected, they are not […]

MHRA Inspection Readiness: What Inspectors Look For in 2026 If you want to remain compliant in the UK pharmaceutical region, it’s not just a matter of ‘getting ready’ at the last minute prior to a Pharmacovigilance inspection. The standards are changing and increasing in rigor as inspectors focus upon the quality system, data integrity and ongoing compliance. Good MHRA inspection readiness enables […]

The industries which require regulation need documentation to function properly. The U.S. Food and Drug Administration together with modern regulators, now require companies to maintain essential records instead of producing unnecessary documentation. The documentation process requires improvement through documentation which will become more intelligent and streamlined with risk assessment according to Good Documentation Practices (GDocP). Moving Toward Lean Quality Thinking Lean […]

The pharmaceutical and medical device industries are entering one of the most significant transformations in decades. The trend toward Global QMSR harmonization is changing how organizations create, execute, and sustain their quality control systems in international settings. This movement is championed by the US and other regulators. Food and Drug Administration and aligned with international expectations, this […]

In 2026, the impact of the GenAI on the pharma industry will be notable in terms of how organizations handle quality assurance. From document review to deviation analysis, AI tools are being positioned as the next big leap in compliance efficiency. However, regulators like the U.S. cc The Food and Drug Administration establishes requirements which demand that […]

In the pharmaceutical industry, pharmaceutical quality failures are rarely the result of a single mistake. More often, they are the outcome of weak systems, broken feedback loops, and ineffective oversight. Modern regulators like the U.S. Food and Drug Administration now emphasize strong Pharmaceutical Quality Systems (PQS) to prevent such failures before they escalate into recalls. Understanding Failures Through […]

The current pharmaceutical industry requires more than compliance-based solutions because its operational landscape has developed into its present state. The U.S. Food and Drug Administration, together with international regulatory bodies, require organizations to prove their commitment to pharmaceutical quality culture and their actual operational practices.   The need for companies to establish trust and track employee performance and manage hybrid worker compliance has become […]